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Abstract
Matrix-assisted laser desorption ionization time-of-ﬂightMALDI-TOF mass spectrometry (MS) is now widely recognized as a powerful tool
with which to identify bacteria and fungi at the species level, and sometimes in a rapid and accurate manner. We report herein an approach
to identify, at the species level, Leishmania promastigotes from in vitro culture. We ﬁrst constructed a reference database of spectra
including the main Leishmania species known to cause human leishmaniasis. Then, the performance of the reference database in identifying
Leishmania promastigotes was tested on a panel of 69 isolates obtained from patients. Our approach correctly identiﬁed 66 of the 69 isolates
tested at the species level with log (score) values superior to 2. Two Leishmania isolates yielded non-interpretable MALDI-TOF MS
patterns, owing to low log (score) values. Only one Leishmania isolate of Leishmania peruviana was misidentiﬁed as the closely related species
Leishmania braziliensis, with a log (score) of 2.399. MALDI-TOF MS is a promising approach, providing rapid and accurate identiﬁcation of
Leishmania from in vitro culture at the species level.
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Introduction
Human leishmaniasis, caused by 21 species of the obligate
intracellular protozoan Leishmania, is one of the most
neglected tropical diseases according to the WHO, despite
the 2 million new cases recorded yearly [1]. This vector-borne
disease encompasses several clinical syndromes, ranging from
self-healing cutaneous infection to life-threatening visceral
infections, partly depending on the Leishmania species involved
[2]. Knowledge of the species involved is critical for predicting
the evolution and prognosis, and for determining the appro-
priate treatment. However, conventional diagnostic tech-
niques, i.e. microscopic examination of Giemsa-stained
smears of infected tissues, in vitro cultivation of clinical samples
on diphasic NNN or axenic media, and Leishmania serology
assays, do not allow diagnosis at the species level [3].
Identiﬁcation at the species level requires molecular biology
techniques such as PCR or sequencing. These molecular
biology techniques remain at an experimental stage, and are
conﬁned to research care centres. The reference standard
method for identifying Leishmania species, as recommended by
the WHO, remains isoenzyme analysis, which is labour-inten-
sive, costly, and conﬁned to reference centres [1]. Thus, no
rapid and simple method for the species identiﬁcation of
Leishmania currently exists.
For approximately 10 years, matrix-assisted laser desorp-
tion ionization time-of-ﬂight (MALDI-TOF) mass spectrome-
try (MS) has been proposed as an alternative to conventional
and routine identiﬁcation methods in clinical microbiological
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laboratories. This identiﬁcation technique was originally
adapted for the identiﬁcation of prokaryotic organisms [4].
New developments have extended its use to a few eukaryotic
organisms, such as yeasts and moulds, making this technique a
straightforward, fast and reliable identiﬁcation method for
bacteria, yeasts and moulds in a cost-effective way [5–7].
However, MALDI-TOF MS has not yet been adapted for the
identiﬁcation of Leishmania or any other protozoan parasites.
In this article, we show how we ﬁrst constructed a reference
mass spectra library (MSL) by using cultures of 56 well-
characterized Leishmania isolates, and then tested it by
identifying a panel of 69 isolates with a MALDI-
TOF MS-based approach.
Materials and Methods
Leishmania isolates and culture
A panel (panel 1) of 56 isolates was used to construct a mass
spectra library, and is summarized in Table 1. The isolates
were provided and accurately identiﬁed with the isoenzyme
method by the Centre National de reference des Leishman-
ioses (CNR-L) (French National Reference Centre for
Leishmaniasis) in Montpellier, France. A different panel
(panel 2) of 69 isolates was used to assess identiﬁcation
performance (Table 2). These isolates were provided by the
CNR-L, the Institut Pasteur of Alger, Algeria, and the Institut
TABLE 1. Main characteristics of the Leishmania isolates furnished by the Centre National de reference des Leishmanioses
included in the reference database
Taxon Isolate Provenance Host CF Zymodem
Leishmania infantum MHOM/EG/87/RTC2 Egypt Homo sapiens VL MON-98
L. infantum MHOM/FR/87/RM1 France Canis familiaris VL MON-108
L. infantum MHOM/TN/80/IPT1 Tunisia H. sapiens VL MON-1
L. infantum MHOM/DZ/82/LIPA59 Algeria H. sapiens CL MON-24
L. infantum MHOM/FR/78/LEM75 France H. sapiens VL MON-1
Leishmania donovani MHOM/IN/00/DEVI India H. sapiens VL MON-2
L. donovani MHOM/IN/96/THAK57 India H. sapiens VL MON-2
L. donovani MHOM/SD/98/LEM3580 Sudan H. sapiens VL MON-18
L. donovani MHOM/ET/67/HU3 Ethiopia H. sapiens VL MON-18
L. donovani MHOM/IN/80/DD8 India H. sapiens VL MON-2
Leishmania archibaldi MHOM/ET/72/GEBRE1 Ethiopia H. sapiens VL MON-82
L. archibaldi MCAN/SD/98/LEM3556 Sudan C. familiaris VL MON-82
Leishmania major MHOM/SU/73/5-ASKH Turkmenistan H. sapiens CL MON-4
L. major MHOM/IL/81/FRIEDLINa Israel H. sapiens CL MON-103
L. major MHOM/TN/2001/LEM4286 Tunisia H. sapiens CL MON-25
L. major MHOM/MA/2003/LEM4685 Morocco H. sapiens CL MON-25
L. major MHOM/YE/76/LEM62 Yemen H. sapiens CL MON-26
Leishmania aethiopica MHOM/ET/72/L100 Ethiopia H. sapiens CL MON-14
L. aethiopica MHOM/ET/91/KASSAYE Ethiopia H. sapiens DCL MON-248
Leishmania killicki MHOM/TN/80/LEM163 Tunisia H. sapiens CL MON-8
L. killicki MHOM/TN/80/LEM180 Tunisia H. sapiens CL MON-8
Leishmania tropica MHOM/MA/95/LEM3015 Morocco H. sapiens CL MON-264
L. tropica MHOM/SU/74/K27 Azerbaijan H. sapiens CL MON-60
L. tropica MHOM/GR/80/GR-L35 Greece H. sapiens CL MON-56
L. tropica 0000/00/84/LEM643 NA NA VL MON-104
L. tropica MRAT/IQ/72/ADHANIS1 Iraq Rattus rattus VL MON-5
Leishmania braziliensis MHOM/BR/75/M2904 Brazil H. sapiens CL MON-165
L. braziliensis MHOM/BR/84/LTB300 Brazil H. sapiens MCL MON-166
L. braziliensis MHOM/BR/82/LTB12JULY82 Brazil H. sapiens MCL MON-208
L. braziliensis MHOM/BR/75/M2903b Brazil H. sapiens CL MON-43
L. braziliensis MHOM/GF/2003/LAV008 FG H. sapiens CL MON-43
Leishmania guyanensis MHOM/GF/98/LEM3657 FG H. sapiens CL MON-45
L. guyanensis MHOM/GF/2003/LEM4570 FG H. sapiens CL MON-45
L. guyanensis MHOM/GF/2004/LAV016 FG H. sapiens CL MON-45
L. guyanensis MHOM/GF/79/LEM85 FG H. sapiens CL MON-45
Leishmania panamensis MHOM/EC/90/CALDERON Equador H. sapiens CL MON-161
L. panamensis MDAS/PA/71/LS94 Panama H. sapiens CL MON-47
Leishmania peruviana MHOM/PE/84/CE49 Peru H. sapiens CL MON-140
Leishmania lainsoni IUBI/BR/00/M12025 Brazil Lutzomyia ubiquitalis None MON-150
L. lainsoni MCUN/BR/85/M9342 Brazil Cuniculus paca None MON-151
Leishmania naifﬁ MDAS/BR/79/M5533 Brazil Dasypus novemcinctus None MON-148
Leishmania amazonensis MHOM/BR/72/M1845 Brazil Proechimys sp. None MON-41
L. amazonensis MHOM/BR/73/M2269 Brazil H. sapiens CL MON-132
L. amazonensis garnhami MHOM/VE/76/JAP78 Venezuela H. sapiens CL MON-41
Leishmania mexicana MNYC/BZ/62/M379 Belize Nyctomys sumichrasti CL MON-40
L. mexicana MHOM/BZ/82/BEL21 Belize H. sapiens CL MON-156
L. mexicana pifanoi MHOM/VE/57/LL1 Venezuela H. sapiens DCL MON-40
Leishmania pifanoi MHOM/VE/57/LL1a Venezuela H. sapiens DCL MON-40
Leishmania deanei MCOE/BR/78/M5088 Brazil Coendou sp. None MON-52
L. deanei MCOE/BR/74/M2674 Brazil Coendou prehensilis CL MON-134
Leishmania arabica MPSA/SA/83/JISH220 Saudi Arabia Psammomys obesus VL MON-99
Leishmania enriettii MCAV/BR/45/L88 Brazil Cavia porcellus CL MON-97
L. enriettii MCAV/BR/95/CUR2 Brazil C. porcellus CL MON-97
Leishmania gerbilli MRHO/CN/60/GERBILLI China Rhombomys opimus CL MON-22
Leishmania turanica MRHO/SU/65/VL Turkmenistan R. opimus VL MON-21
L. turanica MMEL/SU/79/MEL Georgia Meles meles None MON-65
CL, cutaneous leishmaniasis; DCL, diffuse cutaneous leishmaniasis; FG, French Guyana; MCL, mucocutaneous leishmaniasis; NA, not available; VL, visceral leishmaniasis.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 20, 551–557
552 Clinical Microbiology and Infection, Volume 20 Number 6, June 2014 CMI
Pasteur of Tunis (PI-T), Tunisia (Table 2). The isolates were
identiﬁed by isoenzymatic identiﬁcation or by restriction
fragment length polymorphism–PCR (RFLP-PCR) [8]. Only
one isolate (L-68) was identiﬁed by RNA polymerase II gene
sequencing, as described by Croan et al. [9]. Isoenzymatic
identiﬁcation was performed by the CNR-L in Montpellier,
TABLE 2. Identiﬁcation results obtained by matrix-assisted laser desorption ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS) in comparison with the isoenzymatic identiﬁcation for the 69 blind-tested Leishmania samples (incorrect
MALDI-TOF MS results are indicated in bold)
Reference identiﬁcation MALDI-TOF MS
Isolate Source Provenance Host Clinical form Species ID Method Species ID LS value
L-1 PI-T Tunisia H.s VL Leishmania infantum RFLP-PCR L. infantum 2.702
L-2 CNR-L France H.s VL L. infantum IsoE L. infantum 2.527
L-3 PI-A Algeria H.s CL Leishmania killicki IsoE L. killicki 2.53
L-4 CNR-L France H.s CL L. infantum IsoE L. infantum 2.56
L-5 PI-A Algeria H.s VL L. infantum IsoE L. infantum 2.616
L-6 PI-A Algeria H.s CL Leishmania major IsoE L. major 2.578
L-7 CNR-L France H.s VL L. infantum IsoE L. infantum 2.583
L-8 CNR-L NA H.s CL L. infantum IsoE L. infantum 2.455
L-9 CNR-L France H.s CL L. infantum IsoE L. infantum 2.532
L-10 CNR-L France H.s VL L. infantum IsoE L. infantum 2.587
L-11 PI-A Algeria H.s CL L. major IsoE Non-interpretable 1.575
L-12 PI-T Tunisia H.s VL L. infantum IsoE L. infantum 2.573
L-13 PI-A Tunisia H.s VL L. infantum IsoE L. infantum 2.616
L-14 CNR-L France H.s VL L. infantum IsoE L. infantum 2.584
L-15 CNR-L France H.s VL L. infantum IsoE L. infantum 2.513
L-16 CNR-L Peru H.s CL Leishmania peruviana IsoE Leishmania braziliensis 2.399
L-17 CNR-L Tunisia H.s CL L. infantum IsoE L. infantum 2.715
L-18 CNR-L France H.s VL L. infantum IsoE L. infantum 2.351
L-19 CNR-L France H.s VL L. infantum IsoE L. infantum 2.553
L-20 CNR-L France H.s VL L. infantum IsoE L. infantum 2.499
L-21 CNR-L France H.s VL L. infantum IsoE L. infantum 2.45
L-22 PI-T Tunisia H.s VL L. infantum IsoE L. infantum 2.721
L-23 PI-T Tunisia H.s VL L. infantum IsoE L. infantum 2.678
L-24 PI-A Algeria H.s CL L. infantum IsoE L. infantum 2.676
L-25 CNR-L France H.s VL L. infantum IsoE L. infantum 2.582
L-26 CNR-L France H.s VL L. infantum IsoE L. infantum 2.614
L-27 CNR-L France H.s VL L. infantum IsoE L. infantum 2.523
L-28 PI-A Algeria H.s CL L. major IsoE L. major 2.68
L-29 PI-T Tunisia H.s VL L. infantum IsoE L. infantum 2.665
L-30 PI-A Algeria H.s CL L. major IsoE Non-interpretable 1.737
L-31 CNR-L France H.s VL L. infantum IsoE L. infantum 2.53
L-32 PI-A Algeria H.s CL L. major IsoE L. major 2.675
L-33 PI-A Algeria H.s CL L. major IsoE L. major 2.644
L-34 CNR-L France H.s VL L. infantum IsoE L. infantum 2.548
L-35 CNR-L France H.s VL L. infantum IsoE L. infantum 2.581
L-36 CNR-L France H.s CL L. infantum IsoE L. infantum 2.459
L-37 PI-A Algeria P.o None L. major IsoE L. major 2.609
L-38 PI-T Tunisia H.s VL L. infantum IsoE L. infantum 2.684
L-39 CNR-L France H.s VL L. infantum IsoE L. infantum 2.533
L-40 PI-A Algeria H.s CL L. killicki IsoE L. killicki 2.461
L-41 CNR-L Algeria H.s CL L. infantum IsoE L. infantum 2.384
L-42 PI-A Algeria H.s CL L. major IsoE L. major 2.644
L-43 CNR-L Algeria H.s CL L. infantum IsoE L. infantum 2.609
L-44 PI-T Tunisia H.s VL L. infantum IsoE L. infantum 2.588
L-45 PI-T Tunisia H.s VL L. infantum IsoE L. infantum 2.639
L-46 PI-T Tunisia H.s VL L. infantum IsoE L. infantum 2.638
L-47 CNR-L Algeria H.s CL L. infantum IsoE L. infantum 2.541
L-48 PI-A Algeria H.s CL L. infantum RFLP-PCR L. infantum 2.627
L-49 PI-A Algeria H.s CL L. infantum IsoE L. infantum 2.726
L-50 CNR-L France H.s VL L. infantum IsoE L. infantum 2.53
L-51 PI-A Tunisia H.s VL L. infantum IsoE L. infantum 2.62
L-52 PI-A Algeria H.s CL L. infantum RFLP-PCR L. infantum 2.62
L-53 CNR-L France H.s VL L. infantum IsoE L. infantum 2.533
L-54 CNR-L France H.s VL L. infantum IsoE L. infantum 2.579
L-55 CNR-L French Guyana H.s CL L. braziliensis IsoE L. braziliensis 2.44
L-56 CNR-L Colombia H.s CL Leishmania amazonensis IsoE L. amazonensis 2.594
L-57 CNR-L Venezuela H.s DCL L. amazonensis IsoE L. amazonensis 2.468
L-58 CNR-L French Guyana H.s CL Leishmania guyanensis IsoE L. guyanensis 2.52
L-59 CNR-L French Guyana H.s CL L. guyanensis IsoE L. guyanensis 2.495
L-60 CNR-L Belize H.s CL Leishmania mexicana IsoE L. mexicana 2.503
L-61 CNR-L Ethiopia H.s CL Leishmania aethiopica IsoE L. aethiopica 2.209
L-62 CNR-L Iran H.s CL Leishmania tropica IsoE L. tropica 2.465
L-63 CNR-L India H.s VL Leishmania donovani IsoE L. donovani 2.438
L-64 CNR-L Brazil C.f MCL L. braziliensis IsoE L. braziliensis 2.249
L-65 CNR-L Bolivia H.s ML L. braziliensis IsoE L. braziliensis 2.456
L-66 CNR-L Mexico H.s DCL L. mexicana IsoE L. mexicana 2.381
L-67 CNR-L Costa Rica H.s DCL L. guyanensis IsoE L. guyanensis 2.186
L-68 CNR-L Peru H.s CL Leishmania lainsoni RNAIIpol L. lainsoni 2.061
L-69 CNR-L Syria H.s CL L. tropica IsoE L. tropica 2.417
C.f, Canis familiaris; CL, cutaneous leishmaniasis; CNR-L, Centre National de Reference des Leishmanioses, Montpellier, France; DCL, diffuse cutaneous leishmaniasis; H.s, Homo
sapiens; IsoE, isoenzymatic identiﬁcation; LS, log (score); MCL, mucocutaneous leishmaniasis; ML, mucosa leishmaniasis; NA, not available; PI-A, Institut Pasteur of Alger; PI-T, Institut
Pasteur of Tunis, P.o, Psammomys obesus; RFLP-PCR, restriction fragment length polymorphism–PCR; RNAIIpol, RNA II polymerase gene sequencing; VL, visceral leishmaniasis.
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France, and the Institut Pasteur of Alger, Algeria as described
by Rioux et al. [10]. Identiﬁcation by RFLP-PCR was per-
formed by the PI-T as described by Sch€onian et al. [8]. The
‘reference identiﬁcation’ of isolates represented isoenzymatic
identiﬁcation, when available; otherwise the ‘reference iden-
tiﬁcation’ represented the result of the identiﬁcation via
RFLP-PCR.
All isolates were cryoconserved in liquid nitrogen in a tube
containing RPMI medium supplemented with 30% fetal bovine
serum and 20% dimethylsulphoxide at a concentration of
approximately 3 million promastigotes per millilitre. Cultures
were performed as follows. The cryoconserved tubes were
rapidly thawed in a 37°C water bath, and immediately washed
three times with 10 mL of RPMI medium (RPMI
Medium 1640 + 2 mM L-glutamine + 25 mM HEPES; Gibco
BRL, Life Technologies SAS, Saint Aubin, France). Then, the
pellet of promastigotes was suspended in 2 mL of RPMI medium
supplemented with 15% decomplemented fetal bovine serum,
100 UI/mg/L penicillin/streptomycin solution (Gibco BRL), and
100 mg/L kanamycin (Gibco BRL). Eight drops (c. 20 lL/drop)
of this suspension were inoculated in a traditional culture
tube containing Novy–MacNeal–Nicolle medium and incu-
bated for 1 week at 25°C. Then, ﬁve drops of the culture
supernatant were transferred to RPMI medium as described
by Gouzelou et al. [11], and incubated for 1 week at 25°C.
After 7 days of growth, promastigotes were harvested by
centrifugation (10 min at 3000°g) of the RPMI medium, and
then washed three times with 10 mL of 0.9% NaCl. Then, the
promastigote pellet was gently suspended in one drop
(approximately 20 lL) of 0.9% NaCl.
Mass spectra acquisition
A 1-lL drop of the saline solution of promastigotes was
deposited on a spot of a polished steel target (MTP384
polished steel target; Bruker Daltonics, Bremen, Germany) and
air-dried. The Leishmania isolates used to construct the mass
spectra library were deposited in decaplicate, whereas the
Leishmania isolates used to assess identiﬁcation performance
were deposited in quadruplicate. Each spot was then covered
with 1 lL of the matrix solution. The matrix solution was a
daily prepared saturated solution of a-cyano-4-hydroxycin-
namic acid in 50% acetonitrile and 2.5% triﬂuoroacetic acid
(Sigma-Aldrich, Lyon, France). The spectra were acquired after
240 shots in linear mode with a Microﬂex LT instrument
(Bruker Daltonics) in the ion-positive mode with a 337-nm
nitrogen laser. The following adjustments were used: delay,
170 ns; ion source 1 voltage, 20 kV; ion source 2 voltage,
18.5 kV; and mass range, 3–20 kDa. The data were automat-
ically acquired by the AutoXecute of the FlexControl v2.4
software, and exported into MaldiBiotyper v2.1 software.
Only peaks with a signal/noise ratio of ≥3 were considered. A
calibration was performed before and after each run with the
Bruker Bacterial Standard Test calibrator (Bruker Daltonics).
A negative extraction control was spotted on each run to
detect contamination.
Evaluation of the mass spectra quality
With FlexAnalysis 3.3.80.0 software (Bruker Daltonics), the
ﬁrst spectra acquired for each of the 56 isolates (panel 1) was
visualized and then analysed: the peak list (from 3 to 20 kDa)
and the signal/noise ratio (>3) of peaks were recorded.
MSL construction
The MSL was composed of 56 reference mass spectra (MSPs).
An MSP was created for each Leishmania isolate of panel 1
(Table 1). Each MSP was created by combining the results of
ten raw spectra per Leishmania isolate with the ‘MSP creation’
function of the MaldiBiotyper software.
MSL validation
To assess the technical reproducibility of the spectra obtained
with the same biological sample, the log (score) (LS) values of
each raw spectrum composing an MSP were obtained by
comparing each raw spectrum with its proper MSP by use of
the ‘Start identiﬁcation’ function of the MaldiBiotyper soft-
ware. Moreover, to assess the biological reproducibility of the
spectra obtained with each isolate, another subculture of each
isolate was performed. The four raw spectra obtained from
this subculture were blasted against the MSL with the ‘Start
identiﬁcation’ function of the MaldiBiotyper software. The
identiﬁcation result showing the best log (score) value among
the four spots was recorded.
MALDI-TOF MS-based identiﬁcation of Leishmania isolates
Leishmania isolates were identiﬁed in blind tests. Anonymous
Leishmania culture samples were provided to the experimenter
who performed the identiﬁcation as follows. Each of the four
raw spectra obtained for each Leishmania sample were
identiﬁed by comparison with the MSL by use of the ‘Start
identiﬁcation’ function of the MaldiBiotyper software. The best
match and its corresponding LS value were recorded for each
of the four raw spectra. The MALDI-TOF MS-based identiﬁ-
cation of a Leishmania sample was considered to be interpret-
able if the raw spectra with the highest LS value matched with
an MSP of our MSL with an LS value superior to 2. In the
opposite instance, the MALDI-TOF MS-based identiﬁcation
was considered to be non-interpretable. An interpretable
MALDI-TOF MS-based identiﬁcation was considered to be
correct if it matched with the isoenzymatic identiﬁcation or
the RFLP-PCR identiﬁcation.
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Results
Quality of the mass spectra
The 56 spectra showed different proﬁles and several peaks with
good resolution, ranging from3003.528 to 16154.79 Da (Fig. 1).
Furthermore, the 56 spectra analysed were composed of an
average of 67  34 peaks per spectrum (ranging from 15 peaks
to 161), with a signal/noise ratio ranging from 3 to 94.9
(mean = 8.57).
MSP library validation
The LS values obtained by comparing each of the ten raw spectra
composing an MSP with its proper MSP (technical reproducibil-
ity) ranged from 1.843 to 2.918, with a mean value of
2.753  0.09. Only one raw spectrum of the 560 raw spectra
gave an LS value of<2, the LS threshold value required to conﬁrm
good identiﬁcation according to the manufacturer (Table S1).
Reproducibility was excellent, as the raw spectra with the
highest LS values acquired from a different subculture of a
isolate best matched with their proper MSP for 54 of the 56
reference isolates, with LS values ranging from 2.345 to 2.858
(mean = 2.700  0.100). The two remaining subcultures of
reference isolates best matched with an MSP of a different
reference isolate but belonging to the same species, and even
to the same zymodeme: the subculture of Leishmania major
MHOM/MA/2003/LEM4685 (zymodeme MON-25) best
matched with the MSP of the reference isolate L. major
MHOM/TN/2001/LEM4286 (zymodeme MON-25), with an LS
value of 2.671; and the subculture of Leishmania mexicana
MNYC/BZ/62/M379 (zymodeme MON-40) best matched with
the MSP of the reference isolate L. mexicana MHOM/VE/57/
LL1 (zymodeme MON-40), with an LS value of 2.368.
MALDI-TOF MS-based identiﬁcation of Leishmania samples
Of the 69 clinical isolates identiﬁed by MALDI-TOF MS in a
blind test, 67 isolates gave interpretable MALDI-TOF MS-based
identiﬁcation results; that is, the best match of four spots had an
LS value of >2. The LS values of these 67 isolates ranged from
2.061 to 2.726 (mean = 2.536  0.13). Sixty-six of these 67
(95.65% of all isolates) interpretable MALDI-TOF MS results
were correct; that is, the MALDI-TOF MS identiﬁcation was
concordant with the isoenzymatic identiﬁcation or the
RFLP-PCR identiﬁcation at the species level.
Only Leishmania peruviana L-16 was misidentiﬁed, as Leish-
mania braziliensis, with an LS value of 2.399. This sample
matched with the reference of L. peruviana with an LS value of
only 2.075.
The MALDI-TOF MS identiﬁcation was non-interpretable
for the L. major isolates L-11 and L-30, because the best match
of the four spots did not reach the threshold of 2 (LS values of
1.575 and 1.737, respectively).
FIG. 1. Mass spectra of six different isolates of Leishmania included in the reference library.
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Discussion
MALDI-TOF MS is now well adapted to the identiﬁcation of
prokaryotes such as bacteria [4], as well as of eukaryotic
unicellular organisms such as yeasts [6]. More recently, the use
of MALDI-TOF MS-based assays was extended to identify
other organisms, such as moulds, dermatophytes, and even
insects [7,12–13]. However, MALDI-TOF MS has not yet
been used to identify protozoan parasites. This study shows
that this is possible for cultivated Leishmania promastigotes.
We deliberately used a simple protocol consisting of only
washing a rich culture of promastigotes with NaCl. Williams
et al. [14] reported that spectra acquired from whole bacterial
cells treated with 0.9% NaCl were of poor quality as compared
with those acquired from whole bacterial cells treated with
de-ionized water or ethanol. However, de-ionized water lyses
promastigote cells, leading to the lost of cellular contents.
Additionally, our experiments showed that the spectra
obtained from the saline solution of promastigotes were
composed of numerous peaks (ranging from 15 to 161) with
high resolution and intensity, encompassing a large mass/charge
interval (from 3 kDa to approximately 16 kDa). According to
Erhard et al., the quality of the promastigote spectra obtained
was sufﬁcient to ensure identiﬁcation at the species level, as the
spectra clearly exceeded the 17-peak threshold, thereby
ensuring the species speciﬁcity of a spectrum. The good quality
of promastigote spectra in saline solution could be explained by
the relatively low signal emitted by the 0.9% NaCl as compared
with the signals emitted by promastigote cells.
Moreover, this simple protocol provided highly reproduc-
ible spectra. Indeed, technical reproducibility experiments led
to LS values as high as 2.753  0.09. Data concerning the
technical reproducibility are scarce in the microbiology
literature. The only available data that we found for eukaryotes
were for ﬁlamentous fungi. Cassagne et al. [7] reported
technical reproducibility with an LS value of approximately
2.5 when comparing the raw spectra composing an MSP of a
vast panel of moulds with its proper MSP. The reproducibility
results obtained here are superior probably because Leish-
mania promastigotes do not show the phenetic polymorphism
that is commonly found with cultured moulds.
On this basis, we constructed a 56-reference isolate
database, which proved to be able to identify, at the
zymodeme level, a subculture of all of the isolates represented
in the reference database. Indeed, 54 of the 56 subcultures of
the reference isolates matched with their proper MSP (mean
LS value of 2.700  0.10), whereas the two remaining
subcultures best matched with an MSP corresponding to
another reference belonging to the same zymodeme.
When testing our MALDI-TOF MS method for the identi-
ﬁcation of isolates, we found that 95.65% of the blindly tested
samples were correctly identiﬁed. The results were not
interpretable for only two samples, even after a second
identiﬁcation test. Otherwise, only one isolate was misiden-
tiﬁed. This identiﬁcation rate is similar to, and in some cases
even better than, those obtained for other microorganisms.
Seng et al. reported an identiﬁcation rate at the species level of
84.1% for clinical bacterial isolates, Cassagne et al. reported a
rate of >85% for clinical isolates, and De Carolis et al. [15]
reported a rate of 96.8% for a few species of mould [7]. Even
the isolates belonging to species represented in the reference
library by only one or two references, such as Leishmania
lainsoni, Leishmania aethiopica, and Leishmania killicki, were
correctly identiﬁed (with the exception of the misidentiﬁed
isolate of L. peruviana). Notably, the LS values that we obtained
when identifying the clinical Leishmania samples were partic-
ularly high, with a mean of 2.536, which is far above the values
obtained with other eukaryotic organisms, such as ﬁlamentous
fungi (mean = 2.206) [15] and yeasts (mean = 2.225) [16].
Only one L. peruviana isolate was misidentiﬁed as L. brazili-
ensis, with a high LS value (2.399). L. peruviana and L. braziliensis
are two closely related species belonging to the Viannia
subgenus, and L. peruviana is included in the L. braziliensis
complex [17]. For example, isolates of these two species show
very similar multilocus enzyme electrophoresis proﬁles, which
can only be distinguished by the use of mannose phosphate
isomerase [18]. Furthermore, it has been shown that the
sequence of the gene encoding mannose phosphate isomerase
differs between these two species by a single nucleotide,
leading to a change from threonine (L. braziliensis) to arginine
(L. peruviana) [18]. The lack of MALDI-TOF MS-based dis-
crimination between these species is therefore not surprising.
Overall, this study has shown that MALDI-TOF MS is a
promising approach with which to identify Leishmania from
in vitro cultures with high identiﬁcation rates and LS values. The
database that we have built up here constitutes a ﬁrst
prototype that needs to be enlarged in order to increase its
performance. A limitation of the technique for clinical
diagnostic use is the need for cultivated parasites. Neverthe-
less, as compared with molecular biology, this approach offers
great advantages, in particular speed, simplicity, and cost, for
isolate identiﬁcation at the species level.
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